
    
      Participants who meet protocol-defined glycemic rescue criteria will be permitted to have an
      adjustment in the dose(s) of background antihyperglycemic agent (AHA) therapy or addition of
      new AHA therapy as directed by their investigator until the participant no longer meets the
      rescue criteria.
    
  